120 related articles for article (PubMed ID: 1708403)
1. Serotonin and 5-hydroxyindoleacetic acid in plasma. Potential use as peripheral measures of MAO-A activity.
Celada P; Sarrias MJ; Artigas F
J Neural Transm Suppl; 1990; 32():149-54. PubMed ID: 1708403
[TBL] [Abstract][Full Text] [Related]
2. Plasma 5-hydroxyindoleacetic acid as an indicator of monoamine oxidase-A inhibition in rat brain and peripheral tissues.
Celada P; Artigas F
J Neurochem; 1993 Dec; 61(6):2191-8. PubMed ID: 7504085
[TBL] [Abstract][Full Text] [Related]
3. Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement.
Celada P; Pérez J; Alvarez E; Artigas F
J Clin Psychopharmacol; 1992 Oct; 12(5):309-15. PubMed ID: 1282522
[TBL] [Abstract][Full Text] [Related]
4. Serotonin metabolism by monoamine oxidase in rat primary astrocyte cultures.
Fitzgerald LW; Kaplinsky L; Kimelberg HK
J Neurochem; 1990 Dec; 55(6):2008-14. PubMed ID: 1700071
[TBL] [Abstract][Full Text] [Related]
5. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.
Kato T; Dong B; Ishii K; Kinemuchi H
J Neurochem; 1986 Apr; 46(4):1277-82. PubMed ID: 2419508
[TBL] [Abstract][Full Text] [Related]
6. Serotonergic measures in blood and brain and their correlations in rats treated with tranylcypromine, a monoamine oxidase inhibitor.
Malyszko J; Urano T; Serizawa K; Yan D; Kozima Y; Takada Y; Takada A
Jpn J Physiol; 1993; 43(5):613-26. PubMed ID: 7511710
[TBL] [Abstract][Full Text] [Related]
7. Modification of serotonergic and noradrenergic neurotransmissions by repeated administration of monoamine oxidase inhibitors: electrophysiological studies in the rat central nervous system.
Blier P; De Montigny C; Azzaro AJ
J Pharmacol Exp Ther; 1986 Jun; 237(3):987-94. PubMed ID: 2423685
[TBL] [Abstract][Full Text] [Related]
8. Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels.
Griebel G; Curet O; Perrault G; Sanger DJ
Neuropharmacology; 1998 Jul; 37(7):927-35. PubMed ID: 9776388
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
Hewton R; Salem A; Irvine RJ
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1051-7. PubMed ID: 17714093
[TBL] [Abstract][Full Text] [Related]
10. Regional serotonin metabolism in the brain of transgenic mice lacking monoamine oxidase A.
Popova NK; Gilinsky MA; Amstislavskaya TG; Morosova EA; Seif I; De Maeyer E
J Neurosci Res; 2001 Nov; 66(3):423-7. PubMed ID: 11746359
[TBL] [Abstract][Full Text] [Related]
11. Maprotiline in the treatment of endogenous depression: comparison of therapeutic effect with serotonin level in blood platelets.
Mück-Seler D; Deanović Z; Jamnicky B; Jakupcević M; Mihovilović M
Psychopharmacology (Berl); 1983; 79(2-3):262-5. PubMed ID: 6189139
[TBL] [Abstract][Full Text] [Related]
12. Brain serotonin metabolism in hibernation.
Popova NK; Voitenko NN
Pharmacol Biochem Behav; 1981 Jun; 14(6):773-7. PubMed ID: 6166952
[TBL] [Abstract][Full Text] [Related]
13. Effects of local MAO inhibition in the locus coeruleus on extracellular serotonin and 5-HIAA during exposure to sensory and cardiovascular stimuli.
Kaehler ST; Philippu A; Singewald N
Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):187-93. PubMed ID: 10208305
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of homovanillic acid, 5-hydroxyindoleacetic acid and cortisol, and serotonin turnover in depressed patients.
Mitani H; Shirayama Y; Yamada T; Kawahara R
Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):531-4. PubMed ID: 16414168
[TBL] [Abstract][Full Text] [Related]
15. Does brain 5-HIAA indicate serotonin release or monoamine oxidase activity?
Wolf WA; Youdim MB; Kuhn DM
Eur J Pharmacol; 1985 Mar; 109(3):381-7. PubMed ID: 2580723
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of rat brainstem monoamine oxidase activity by CGP 6085 A.
Hurst JH; Kulakowski EC
Life Sci; 1986 Oct; 39(16):1471-7. PubMed ID: 2430159
[TBL] [Abstract][Full Text] [Related]
17. Serotonin metabolism and its enzymic activities in joint diseases.
Igari T; Shimamura T
Clin Orthop Relat Res; 1979; (139):232-49. PubMed ID: 455840
[TBL] [Abstract][Full Text] [Related]
18. Comparison of changes in serotonergic measures in whole blood or plasma and brain in rats given nicotine and/or stresses.
Takada A; Urano T; Yoshida M; Takada Y
Pol J Pharmacol; 1996; 48(2):173-7. PubMed ID: 9112647
[TBL] [Abstract][Full Text] [Related]
19. [Effect of prolonged cold exposure on monoamine oxidase activity and kinetics and on serotonin metabolism in the rat brain].
Molodtsova GF
Biull Eksp Biol Med; 1983 Sep; 96(9):16-8. PubMed ID: 6193823
[TBL] [Abstract][Full Text] [Related]
20. Effects of acute and repeated administration of amiflamine on monoamine oxidase inhibition in the rat.
Ask AL; Fagervall I; Jonze M; Kelder D; Nygren R; Ross SB
Biochem Pharmacol; 1984 Sep; 33(18):2839-47. PubMed ID: 6477643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
